Injectable pH-responsive carboxymethyl cellulose hydrogel for sustained delivery of IL-22 in the treatment of alcoholic liver disease
A smart gel system slowly releases an immune-protective protein to treat liver inflammation in mice, suggesting a gentler approach to alcoholic liver disease.
Researchers developed a pH-responsive hydrogel system for sustained IL-22 delivery that outperformed free IL-22 in treating alcoholic liver disease in mice. The system works by suppressing endoplasmic reticulum stress through the AMPK/SIRT1 signaling pathway.
What the study was
- Study design
- Preclinical (in vivo murine model)
- Population
- Mouse model of alcoholic liver disease
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Journal of Nanobiotechnology
Why it surfaced
Off-watchlist (ALD, not cancer/heme). Animal model only. Low relevance to current watchlist.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.